MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • MDS Virtual Congress 2020

    Tardive Dystonia Successfully treated with DBS

    M. Ferreira Cordellini, D. Benzecry Almeida (Curitiba, Brazil)

    Objective: To demonstrate a successful treatment of neuroleptic-induced generalized dystonia with DBS Background: Male patient, 30 years old. At thirteen years of age, was diagnosed…
  • MDS Virtual Congress 2020

    Cerebellar deep brain stimulation for secondary dystonia: A Case Report

    S.Z Lin, H.X Li, CC. Zhang, Y.H Wang, Y.W Wu, D.Y Li (Shanghai, China)

    Objective: To evaluate whether cerebellum deep brain stimulation (DBS) is effective in patient with secondary dystonia and to compare which target in cerebellum is more…
  • MDS Virtual Congress 2020

    Frequency and phenotypic spectrum of ANO3 dystonia: A single-center cohort study

    L.T Jiang, L.X Li, Y. Liu, X.L Zhang, Y.G Pan, L.J Jin (Shanghai, China)

    Objective: To further clarify the spectrum and frequency of ANO3 rare variants in Chinese populations with primary dystonia. Background: Dystonia is a movement disorder with…
  • MDS Virtual Congress 2020

    Development of novel treatment strategies for SGCE dystonia using patient-derived induced pluripotent stem cells (iPSCs)

    S. Staege, A. Kutschenko, P. Seibler, K. Grütz, A. Hermann, F. Wegner (Hannover, Germany)

    Objective: What are the underlying pathological mechanisms of myoclonus dystonia (DYT-SGCE)? Background: Myoclonus dystonia (DYT-SGCE, DYT11) is a combined dystonia characterized by alcohol-sensitive myoclonic-like appearance…
  • MDS Virtual Congress 2020

    Probing the Parieto-Premotor Network in Writer’s Cramp Using Transcranial Magnetic Stimulation

    J. Park, P. Mathew, J. Sackett, T. Wu, M. Villegas, M. Hallett (Goyang, Republic of Korea)

    Objective: We aimed to probe the parieto-premotor network using transcranial magnetic stimulation (TMS), and further investigate its influence on the motor cortex in patients with…
  • MDS Virtual Congress 2020

    Parkinson’s Disease in Israel – Initial Symptoms and Comorbidities from 20 years of Follow Up in a Population-based Cohort

    Y. Barer, N. Gavrielov, P. Coloma, M. Martinec, I. Korolev, I. Goldshtein (Tel Aviv, Israel)

    Objective: To describe the epidemiology of Parkinson’s disease (PD) in Israel during a 20-year period, 2000–2019, and to characterize initial symptoms and comorbidities of PD…
  • MDS Virtual Congress 2020

    Application of a Simple Parkinson’s Disease Risk Score in a Longitudinal Population Based Cohort

    K. Marini, P. Mahlknecht, F. Tutzer, H. Stockner, A. Gasperi, A. Djamshidian-Tehrani, P. Willeit, S. Kiechl, J. Willeit, G. Rungger, A.J Noyce, A. Schrag, W. Poewe, K. Seppi (Innsbruck, Austria)

    Objective: To apply the PREDICT-PD algorithm of risk indicators for Parkinson’s disease (PD), in a prospective community-based study (the Bruneck Study), representative of the general…
  • MDS Virtual Congress 2020

    Sulpiride-induced Parkinsonism in Peptic Ulcer and Gastroesophageal Reflux Disease Patients: A Nationwide Population-Based Study

    C.Y Wei, M.C Lin, W.M Kung (Changhua County, Taiwan)

    Objective: This study aimed to investigate the risk factors and the cumulative daily dose associated with sulpiride-induced parkinsonism (SIP) in peptic ulcer disease (PUD) and…
  • MDS Virtual Congress 2020

    Movement Disorders in Spanish Cathedrals

    P.J Garcia-Ruiz, J.C Martinez Castrillo, L. Diaz Feliz (Madrid, Spain)

    Objective: To review Movement Disorders represented in some Spanish Cathedrals. Background: Movement Disorders have a recent history in medicine but it is possible to find…
  • MDS Virtual Congress 2020

    Deutetrabenazine for Huntington’s disease chorea—A Single Center’s Experience

    D. Fischer, R. Caskey, M. Dean, V. Sung (Birmingham, AL, USA)

    Objective: To evaluate real-world use and outcomes with deutetrabenazine for Huntington’s disease. Background: Grade A evidence for Huntington’s disease chorea treatment includes tetrabenazine and deutetrabenazine.…
  • « Previous Page
  • 1
  • …
  • 122
  • 123
  • 124
  • 125
  • 126
  • …
  • 149
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • #24970 (not found)
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • To be or not to bupropion: a drug-induced parkinsonism?
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley